Acarix, a leader in AI-driven and acoustics-based cardiac diagnostics, has announced that its President and CEO, Aamir Mahmood, has increased his investment in the company.
On February 13, Mahmood acquired 2,300,257 shares at an average price of SEK 0.22, further strengthening his personal stake in Acarix. After the acquisition, the total number of shares held is 7,704,824 and 50,000,000 stock options.
“I am very optimistic about Acarix’s future,” said Mahmood. “This investment reflects my confidence in our strategy and our ability to generate long-term value for shareholders. I look forward to working with our team to drive continued growth and innovation.”